Capital Surgical Company Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 21-12-2024
- Paid Up Capital ₹ 0.79 M
as on 21-12-2024
- Company Age 58 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.50 Cr
as on 21-12-2024
- Revenue %
(FY 2022)
- Profit 263.32%
(FY 2022)
- Ebitda 146.07%
(FY 2022)
- Net Worth 7.47%
(FY 2022)
- Total Assets 32.83%
(FY 2022)
About Capital Surgical Company
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.79 M.
The company has closed loans amounting to ₹1.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ajay Chopra, Shashi Chopra, Man Chopra, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1966PTC004608
- Company No.
004608
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 1966
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Capital Surgical Company?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Chopra  | Director | 23-Apr-1991 | Current |
| Shashi Chopra | Director | 01-Dec-2020 | Current |
| Man Chopra | Director | 01-Dec-2020 | Current |
| Harsh Chopra | Director | 01-Dec-2020 | Current |
| Subhash Chopra | Director | 01-Jul-1970 | Current |
| Jatin Chopra | Director | 30-Jun-2001 | Current |
Financial Performance of Capital Surgical Company.
Capital Surgical Company Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 263.32% increase in profit. The company's net worth moved up by a moderate rise of 7.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Capital Surgical Company?
In 2019, Capital Surgical Company had a promoter holding of 66.45% and a public holding of 33.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 29 Sep 2000 | ₹6.00 M | Satisfied |
Oriental Bank Of Commerce Creation Date: 04 Jul 2000 | ₹1.00 M | Satisfied |
Oriental Bank Of Commerce Creation Date: 25 Oct 1999 | ₹8.00 M | Satisfied |
How Many Employees Work at Capital Surgical Company?
Capital Surgical Company has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Capital Surgical Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Capital Surgical Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
